Back in May, AbbVie’s Allergan Aesthetics unit signed away $550 million in cash to scoop up drugmaker Soliton and its body sculpting device Resonic. Now, the FTC is requesting a bit more time to review the proposed merger.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,